Valentini Vincenzo et al. (eds.) Multidisciplinary Management of Rectal Cancer: Questions and Answers

Springer, 2012. — 354 p. — ISBN: 978-3-642-25004-0This book seeks to promote an integrated approach among the various specialists involved in the management of rectal cancer with a view to ensuring that treatment is tailored appropriately to the individual patient. For ease of use, a question and answer format is employed. The focus is on those issues typically confronted during daily clinical practice in relation to risk factors, imaging, surgery, radiotherapy, and chemotherapy. The services of an outstanding panel of authors representative of the major European oncological societies have been acquired in order to formulate the questions and provide the answers. All who need assistance in addressing concerns that arise from the need for multidisciplinary management of rectal cancer will find the book to be an ideal source of helpful information.What Do We Consider Cancer of the Rectum?
What Is the Ongoing Recommendation in the Management of Rectal Cancer?
Q&As on Risk Factor Identification
What Prognostic Clinical Factors Must Be Considered Before Treatment?
What Are the Relevant Imaging Factors to Optimize Treatment Decisions?
What Biochemical and Molecular Biological Factors Have Greater Relevance to Treatment Decisions?
Do Different Populations of Rectal Cancer Exist?
Q&As on Imaging
How Can We Identify Tumour Penetration?
How Can We Identify Mesorectal Fascia Involvement?
How Can We Identify Nodal Involvement?
How Can We Identify Pathologic Complete Responders After Radiochemotherapy?
How Can We Identify Local Relapse?
Q&As on Radiotherapy
When Should Preoperative Short-Course Radiotherapy or Long-Course Chemoradiotherapy Be Performed?
Should We Tailor the Delineation of Pelvic Structures According to Tumor Presentation?
What Is the Role of IMRT and IGRT in Rectal Cancer?
What Are the Dose-Volume Constraints to Reduce Late Toxicity?
What Is the Contribution of Intraoperative Radiotherapy (IORT) in Tailoring Local Therapy in Primary or Recurrent Rectal Cancer?
What Is the Contribution of Brachytherapy in Tailoring Local Therapy?
Q&As on Chemotherapy
Should Oxaliplatin Be Added to Preoperative Chemoradiation?
Should Biologic Targeted Agents Be Combined with Preoperative Chemoradiation in Rectal Cancer?
Should Upfront Chemotherapy Precede Preoperative Chemoradiation and Surgery?
How to Achieve Long-Term Survival in Patients with Metastatic Rectal Cancer?
Will Adjuvant Chemotherapy Improve Outcome After Preoperative Chemoradiation?
Q&As on Surgery
How to Evaluate the Quality of Surgery? Suggestions for Critical Reading of Surgical and Pathological Reports
How Is Nerve-Sparing Surgery Well Performed?
Is Laparoscopic Rectal Surgery the Gold Standard?
Is a Diverting Stoma Always Necessary for a Low Anterior Resection of a Rectal Cancer?
Will Extralevator Abdominoperineal Excision Become the New Gold Standard?
Which Patients Do Benefit from Extended Resections in Case of Locally Advanced Rectal Cancer?
Can Standard Surgical Procedure Reliably Be Avoided in Major Responders After Radio(chemo)therapy?
Q&As on Pathology
What Is the Correct Procedure for Handling the Surgical Specimen?
What Is the Prognostic Value of (y)pT and (y)pN?
What Is the Prognostic Value of CRM Involvement?
What Is the Prognostic Value of TRG?
Q&As on Multidisciplinary Team Management
What Are the Recommendations to Ensure a Successful Multidisciplinary Team in Rectal Cancer?
What Is the Appropriate Timetable for Tailored Follow-up?
How Should Data Be Shared and Rapid Learning Health Care Promoted?